New transplant approach opens donor options for blood cancer patients

NCT ID NCT01203722

First seen Feb 19, 2026 · Last updated May 15, 2026 · Updated 12 times

Summary

This study tested a bone marrow transplant using donors who are not perfectly matched or first-degree relatives, for people with blood cancers. The goal was to see if this approach could control the cancer with acceptable side effects like graft-versus-host disease. 87 participants received a reduced-intensity transplant along with drugs to prevent complications. The study aimed to find a safe way to expand donor options for those who lack a perfect match.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Baltimore, Maryland, 21231-2410, United States

Conditions

Explore the condition pages connected to this study.